Vickie M Mays1, Audrey L Jones, Ayesha Delany-Brumsey, Courtney Coles, Susan D Cochran. 1. *Department of Health Policy and Management, UCLA Fielding School of Public Health †UCLA Center for Bridging Research, Innovation, Training and Education for Minority Health Disparities Solutions, Los Angeles, CA ‡Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA §Vera Institute of Justice, New York, NY.
Abstract
BACKGROUND: Experiences of discrimination in health care settings may contribute to disparities in mental health outcomes for blacks and Latinos. We investigate whether perceived discrimination in mental health/substance abuse visits contributes to participants' ratings of treatment helpfulness and stopped treatment. RESEARCH METHODS: We used data from 3 waves of the California Quality of Life Survey, a statewide population-based telephone survey assessing mental health/substance disorders and their treatment. In a sample of 1099 adults (age 18-72) who indicated prior year mental health/substance abuse visits, we examined: experiences of discrimination that occurred during health care and mental health/substance abuse visits, ratings of treatment helpfulness, and reports of stopping treatment early. RESULTS: Fifteen percent of California adults reported discrimination during a health care visit and 4% specifically during mental health/substance abuse visits. Latinos, the uninsured, and those with past year mental disorders were twice as likely as others to report health care discrimination [adjusted odds ratio (AORs)=2.08, 2.77, and 2.51]. Uninsured patients were 7 times more likely to report discrimination in mental health/substance abuse visits (AOR=7.27, P<0.01). The most commonly reported reasons for health care discrimination were race/ethnicity for blacks (52%) and Latinos (31%), and insurance status for whites (40%). Experiences of discrimination in mental health/substance abuse visits were associated with less helpful treatment ratings for Latinos (AOR=0.09, P<0.05) and whites (AOR=0.25, P<0.01), and early treatment termination for blacks (AOR=13.38, P<0.05). CONCLUSIONS: Experiences of discrimination are associated with negative mental health/substance abuse treatment experiences and stopped treatment, and could be a factor in mental health outcomes.
BACKGROUND: Experiences of discrimination in health care settings may contribute to disparities in mental health outcomes for blacks and Latinos. We investigate whether perceived discrimination in mental health/substance abuse visits contributes to participants' ratings of treatment helpfulness and stopped treatment. RESEARCH METHODS: We used data from 3 waves of the California Quality of Life Survey, a statewide population-based telephone survey assessing mental health/substance disorders and their treatment. In a sample of 1099 adults (age 18-72) who indicated prior year mental health/substance abuse visits, we examined: experiences of discrimination that occurred during health care and mental health/substance abuse visits, ratings of treatment helpfulness, and reports of stopping treatment early. RESULTS: Fifteen percent of California adults reported discrimination during a health care visit and 4% specifically during mental health/substance abuse visits. Latinos, the uninsured, and those with past year mental disorders were twice as likely as others to report health care discrimination [adjusted odds ratio (AORs)=2.08, 2.77, and 2.51]. Uninsured patients were 7 times more likely to report discrimination in mental health/substance abuse visits (AOR=7.27, P<0.01). The most commonly reported reasons for health care discrimination were race/ethnicity for blacks (52%) and Latinos (31%), and insurance status for whites (40%). Experiences of discrimination in mental health/substance abuse visits were associated with less helpful treatment ratings for Latinos (AOR=0.09, P<0.05) and whites (AOR=0.25, P<0.01), and early treatment termination for blacks (AOR=13.38, P<0.05). CONCLUSIONS: Experiences of discrimination are associated with negative mental health/substance abuse treatment experiences and stopped treatment, and could be a factor in mental health outcomes.
Authors: Nancy Krieger; Anna Kosheleva; Pamela D Waterman; Jarvis T Chen; Karestan Koenen Journal: Am J Public Health Date: 2011-07-21 Impact factor: 9.308
Authors: William J Hall; Mimi V Chapman; Kent M Lee; Yesenia M Merino; Tainayah W Thomas; B Keith Payne; Eugenia Eng; Steven H Day; Tamera Coyne-Beasley Journal: Am J Public Health Date: 2015-10-15 Impact factor: 9.308
Authors: Benjamin Lê Cook; Samuel H Zuvekas; Nicholas Carson; Geoffrey Ferris Wayne; Andrew Vesper; Thomas G McGuire Journal: Health Serv Res Date: 2013-07-16 Impact factor: 3.402
Authors: Babak Tofighi; Arthur Robin Williams; Chemi Chemi; Selena Suhail-Sindhu; Vicky Dickson; Joshua D Lee Journal: Subst Use Misuse Date: 2019-08-20 Impact factor: 2.164
Authors: Serena MacDonald; Colleen Judge-Golden; Sonya Borrero; Xinhua Zhao; Maria K Mor; Leslie R M Hausmann Journal: Med Care Date: 2020-05 Impact factor: 2.983
Authors: Adam G Horwitz; Taylor McGuire; Danielle R Busby; Daniel Eisenberg; Kai Zheng; Jacqueline Pistorello; Ronald Albucher; William Coryell; Cheryl A King Journal: J Affect Disord Date: 2020-04-18 Impact factor: 4.839
Authors: Yajaira A Cabrera Tineo; Frank R Dillon; Melissa M Ertl; Roberto Rentería; Mario De La Rosa Journal: Int J Ment Health Addict Date: 2020-09-22 Impact factor: 3.836